STAGE IIB NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIB NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: targeted pill before surgery for lung cancer
Disease control OngoingThis study tests whether giving the targeted drug osimertinib before surgery can shrink tumors in people with early-stage EGFR-mutant non-small cell lung cancer. About 27 adults with stage I to IIIA disease will receive the drug before their operation. The main goal is to see how…
Matched conditions: STAGE IIB NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to boost lung cancer fight
Disease control OngoingThis trial is testing a new way to give radiation therapy for people with stage II-III non-small cell lung cancer that cannot be removed with surgery. Instead of standard daily radiation for many weeks, patients receive a shorter, higher-dose course (hypofractionated radiation) a…
Matched conditions: STAGE IIB NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC